Pfizer CentreOne Wins Medicine Maker CDMO of the Year Award
Why the Medicine Maker CDMO of the Year Nod Matters
The first annual CDMO of the Year Award by the Medicine Maker has wrapped up for 2022 and we’re pleased to announce that Pfizer CentreOne has been crowned the winner!
Among ten finalists, Pfizer CentreOne received the most online votes in a reader-selected competition. Here, our General Manager Andrew Moore talks about why this win matters and what it means for Pfizer CentreOne this year.
What is the Medicine Maker CDMO of the Year Award?
An established and trusted publication within the pharmaceutical industry, the Medicine Maker launched its first ever CDMO of the Year Award in early 2022.
Awards hold meaning when they come from respected source; when they recognize an important distinction; when the competition is among peers; and perhaps even more when the choice comes from an open vote.
The goal of this award is to celebrate the best contract development and manufacturing organizations and their employees via a public vote. Votes were cast across six categories, with the CDMO of the Year title highly sought after.
Although ten finalists were chosen for each category, this was also an open vote award, meaning that voters also had the choice to cast votes for CDMOs not on the list.
What does it mean?
This win is particularly meaningful to Pfizer CentreOne and the team because it was the result of a voters’ choice and open vote award by such a highly regarded pharmaceutical publication.
To be acknowledged as the CDMO of the year among such esteemed industry peers is truly significant.
Our people work every day to live up to the confidence our customers place in us as their CDMO partner of choice, to meet our commitments and be a great partner.
A win like this is clear evidence that we are achieving our goals. It makes all of us proud and determined to continue to deliver for our customers and ultimately for patients around the world.
Awards like these enable us to showcase the skills, capabilities and dedication of our teams here at Pfizer CentreOne.
To be named as the CDMO of the Year highlights the scale of innovation and achievements we’re currently making, and makes us even prouder to serve our partners and their patients.